Total Payments
$3,525
2024 Payments
$919.53
Companies
19
Transactions
97
Medicare Patients
3,254
Medicare Billing
$668,889
Payment Breakdown by Category
Food & Beverage$3,443 (97.7%)
Education$81.58 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,443 | 93 | 97.7% |
| Education | $81.58 | 4 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $1,570 | 40 | $0 (2023) |
| Amgen Inc. | $762.97 | 19 | $0 (2024) |
| Marco Ophthalmic, Inc. | $276.56 | 7 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $205.57 | 6 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $188.96 | 6 | $0 (2021) |
| Lombart Brothers, Inc. | $90.91 | 2 | $0 (2020) |
| OPTOS, INC. | $85.42 | 1 | $0 (2018) |
| Allergan, Inc. | $74.75 | 2 | $0 (2022) |
| BIOTISSUE HOLDINGS INC. | $47.52 | 2 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $35.02 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $919.53 | 21 | Amgen Inc. ($762.97) |
| 2023 | $790.95 | 18 | Horizon Therapeutics plc ($774.58) |
| 2022 | $523.78 | 17 | Horizon Therapeutics plc ($425.04) |
| 2021 | $419.09 | 14 | Horizon Therapeutics plc ($326.49) |
| 2020 | $261.71 | 10 | Lombart Brothers, Inc. ($90.91) |
| 2019 | $260.48 | 7 | Bausch & Lomb, a division of Bausch Health US, LLC ($99.99) |
| 2018 | $162.66 | 4 | OPTOS, INC. ($85.42) |
| 2017 | $186.74 | 6 | Marco Ophthalmic, Inc. ($137.82) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $119.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/22/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $27.92 | General |
| 07/16/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $118.23 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $143.17 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $128.64 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $118.58 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $1.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $110.93 | General |
| Category: TEPEZZA | ||||||
| 11/29/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: TEPEZZA | ||||||
| 11/08/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: TEPEZZA | ||||||
| 10/26/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: TEPEZZA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 690 | 2,535 | $661,537 | $131,725 |
| 2022 | 16 | 742 | 4,970 | $747,417 | $158,440 |
| 2021 | 19 | 999 | 6,114 | $1.0M | $213,433 |
| 2020 | 16 | 823 | 5,810 | $849,533 | $165,292 |
Total Patients
3,254
Total Services
19,429
Medicare Billing
$668,889
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 63 | 63 | $174,978 | $36,724 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 177 | 177 | $85,845 | $19,877 | 23.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 143 | 194 | $45,590 | $11,196 | 24.6% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2023 | 31 | 46 | $85,500 | $9,961 | 11.7% |
| 67900 | Repair of brow paralysis | Facility | 2023 | 24 | 24 | $67,804 | $9,326 | 13.8% |
| 15730 | Creation of flap graft to midface | Facility | 2023 | 13 | 14 | $53,200 | $9,266 | 17.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 11 | 1,762 | $17,620 | $8,006 | 45.4% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 14 | 14 | $48,750 | $7,407 | 15.2% |
| 67966 | Removal of over 1/4 of eyelid margin and repair of eyelid | Facility | 2023 | 11 | 12 | $24,326 | $4,416 | 18.2% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 15 | 25 | $12,000 | $3,001 | 25.0% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 89 | 89 | $17,800 | $2,769 | 15.6% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 21 | 22 | $7,106 | $2,584 | 36.4% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 12 | 14 | $5,224 | $2,464 | 47.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $8,090 | $2,290 | 28.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 19 | 31 | $2,480 | $1,262 | 50.9% |
| 67840 | Removal of growth of eyelid | Facility | 2023 | 13 | 14 | $5,224 | $1,177 | 22.5% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 69 | 75 | $198,000 | $44,035 | 22.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 15 | 4,100 | $41,000 | $18,981 | 46.3% |
| 15730 | Creation of flap graft to midface | Facility | 2022 | 20 | 21 | $79,800 | $14,203 | 17.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 148 | 235 | $55,225 | $13,862 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 122 | 122 | $59,170 | $13,588 | 23.0% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2022 | 42 | 43 | $105,300 | $9,565 | 9.1% |
| 68700 | Plastic repair of tear duct | Facility | 2022 | 16 | 17 | $29,785 | $8,564 | 28.8% |
| 67900 | Repair of brow paralysis | Facility | 2022 | 19 | 19 | $55,500 | $7,511 | 13.5% |
| 68320 | Repair of eyelid lining with graft from external eye | Facility | 2022 | 19 | 21 | $27,675 | $6,400 | 23.1% |
About Dr. Samuel Gallo, MD
Dr. Samuel Gallo, MD is a Ophthalmology healthcare provider based in Dublin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609801489.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Gallo, MD has received a total of $3,525 in payments from pharmaceutical and medical device companies, with $919.53 received in 2024. These payments were reported across 97 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,443).
As a Medicare-enrolled provider, Gallo has provided services to 3,254 Medicare beneficiaries, totaling 19,429 services with total Medicare billing of $668,889. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Dublin, OH
- Active Since 07/11/2006
- Last Updated 09/24/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609801489
Products in Payments
- TEPEZZA (Drug) $1,557
- TEPEZZA (Biological) $762.97
- OPD-III (Device) $367.47
- ACTHAR (Biological) $237.55
- LOTEMAX SM (Drug) $169.63
- Monaco (Device) $85.42
- BOTOX COSMETIC (Biological) $57.00
- Rhopressa (Drug) $35.02
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $29.41
- DSUVIA (Drug) $21.81
- XEOMIN (Biological) $21.49
- Cequa (Drug) $19.76
- PROKERA (Device) $19.60
- ZYLET (Drug) $19.33
- Xeomin (Biological) $18.03
- VUITY (Drug) $17.75
- XIIDRA (Drug) $16.94
- PROLENSA (Drug) $14.29
- TYRVAYA (Drug) $13.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Dublin
Louis Chorich, Md, MD
Ophthalmology — Payments: $40,912
Ophthalmology $40,912
Glendon Smalley, M.d, M.D
Ophthalmology — Payments: $35,453
Ophthalmology $35,453
Dr. Sugat Patel, Md, MD
Ophthalmology — Payments: $32,090
Ophthalmology $32,090
Dino Klisovic, M.d, M.D
Ophthalmology — Payments: $20,046
Ophthalmology $20,046
Dr. Dominic Buzzacco, M.d, M.D
Ophthalmology — Payments: $11,144
Ophthalmology $11,144
Dr. Johnstone Kim, Md, MD
Ophthalmology — Payments: $10,444
Ophthalmology $10,444